{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:51:42Z","timestamp":1791046302750,"version":"4.1.0"},"reference-count":70,"publisher":"Japanese Society of Allergology","issue":"4","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T00:00:00Z","timestamp":1430265600000},"content-version":"vor","delay-in-days":1944,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2010]]},"DOI":"10.2332\/allergolint.10-rai-0261","type":"journal-article","created":{"date-parts":[[2010,12,13]],"date-time":"2010-12-13T06:12:44Z","timestamp":1292220764000},"page":"325-332","source":"Crossref","is-referenced-by-count":52,"title":["Genetic Markers and Danger Signals in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis"],"prefix":"10.2332","volume":"59","author":[{"given":"Wen-Hung","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuen-Iu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1154","reference":[{"key":"10.2332\/allergolint.10-RAI-0261_bb0005","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0010","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1111\/1523-1747.ep12388434","article-title":"The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification","volume":"102","author":"Roujeau","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0015","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"NEngl J Med"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archderm.1990.01670250049006","article-title":"The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients","volume":"126","author":"Chan","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0025","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ophtha.2004.11.035","article-title":"Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome","volume":"112","author":"Di Pascuale","year":"2005","journal-title":"Ophthalmology"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0030","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archderm.1987.01660330071012","article-title":"Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients","volume":"123","author":"Revuz","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0035","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s001340050492","article-title":"Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study","volume":"23","author":"Lebargy","year":"1997","journal-title":"Intensive Care Med"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0040","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1346-8138.1998.tb02450.x","article-title":"Toxic epidermal necrolysis with severe gastrointestinal mucosal cell death: a patient who excreted long tubes of dead intestinal epithelium","volume":"25","author":"Sugimoto","year":"1998","journal-title":"J Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0045","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/00006534-200209010-00008","article-title":"Outcome of patients with toxic epidermal necrolysis syndrome revisited","volume":"110","author":"Ducic","year":"2002","journal-title":"Plast Reconstr Surg"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0050","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1365-2133.1996.tb06976.x","article-title":"Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis","volume":"134","author":"Paul","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0055","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0060","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.tpj.6500356","article-title":"A marker for Stevens-Johnson syndrome\u2026: ethnicity matters","volume":"6","author":"Lonjou","year":"2006","journal-title":"Pharmacogenomics J"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0070","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2217\/14622416.9.11.1617","article-title":"HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"9","author":"Kaniwa","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0075","unstructured":"Allele Frequencies in Worldwide Populations. Available from http:\/\/www.allelefrequencies.net\/."},{"key":"10.2332\/allergolint.10-RAI-0261_bb0080","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1528-1167.2008.01719.x","article-title":"Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B 1502 allele in Thai population","volume":"49","author":"Locharernkul","year":"2008","journal-title":"Epilepsia"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0085","article-title":"Association of HLA-B*1502 with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson Syndrome in Malaysian population","author":"Chang","year":"2008"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0090","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.humimm.2004.08.056","article-title":"HLA-A, -B, -Cw, -DQA1, -DQB1 and -DRB1 alleles and KIR alleles in a Hindu population from Punjab, India","volume":"65","author":"Rajalingam","year":"2004","journal-title":"Human Immunology"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0095","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4103\/0378-6323.57718","article-title":"Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians","volume":"75","author":"Mehta","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0100","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1528-1167.2009.02269.x","article-title":"HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions","volume":"51","author":"Ikeda","year":"2010","journal-title":"Epilepsia"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0105","first-page":"550","article-title":"HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese","volume":"14","author":"Ueta","year":"2008","journal-title":"Mol Vis"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0110","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0115","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/FPC.0b013e328330a3b8","article-title":"Strong association between HLA-B 5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population","volume":"19","author":"Tassaneeyakul","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0120","doi-asserted-by":"crossref","first-page":"616","DOI":"10.2340\/00015555-0528","article-title":"HLA-B allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions","volume":"88","author":"Kano","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","article-title":"A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs","volume":"18","author":"Lonjou","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0130","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","article-title":"Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir","volume":"359","author":"Mallal","year":"2002","journal-title":"Lancet"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0135","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B*5701 screening for hypersensitivity to abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N Engl J Med"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0140","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1086\/595890","article-title":"Should HLA-B*5701 screening be performed in every ethnic group before starting abacavir?","volume":"48","author":"Park","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0145","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells","volume":"114","author":"Nassif","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0150","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1172\/JCI119505","article-title":"Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones","volume":"100","author":"Schnyder","year":"1997","journal-title":"J Clin Invest"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0300-483X(95)03253-C","article-title":"T cell immune responses to haptens. Structural models for allergic and autoimmune reactions","volume":"107","author":"Weltzien","year":"1996","journal-title":"Toxicology"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00130832-200208000-00003","article-title":"Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept","volume":"2","author":"Pichler","year":"2002","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0165","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1124\/mol.63.3.732","article-title":"Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones","volume":"63","author":"Naisbitt","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0170","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaci.2007.06.017","article-title":"HLA-B*1502-bound peptides: implications for the pathogenesis of carbamazepine- induced Stevens-Johnson syndrome","volume":"120","author":"Yang","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0175","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.4049\/jimmunol.158.4.1660","article-title":"Polymorphism in the alpha 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity","volume":"158","author":"Barber","year":"1997","journal-title":"J Immunol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0180","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.4049\/jimmunol.138.9.2831","article-title":"Human T cell clones use a CD3-associated surface antigen recognition structure to exhibit both NK-like and allogeneic cytotoxic reactivity","volume":"138","author":"David","year":"1987","journal-title":"J Immunol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0185","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2249.2000.01119.x","article-title":"Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors","volume":"119","author":"Le Cleach","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0190","series-title":"Immunobiology: The Immune System in Health and Disease","author":"Janeway","year":"2001"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0195","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.0022-202X.2004.23439.x","article-title":"Evaluation of the potential role of cytokines in toxic epidermal necrolysis","volume":"123","author":"Nassif","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0200","doi-asserted-by":"crossref","first-page":"16183","DOI":"10.1074\/jbc.M212188200","article-title":"Intracellular localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological conditions","volume":"278","author":"Viard-Leveugle","year":"2003","journal-title":"J Biol Chem"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nm0198-031","article-title":"Downregulation of Fas ligand by shedding","volume":"4","author":"Tanaka","year":"1998","journal-title":"Nat Med"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0210","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4049\/jimmunol.170.2.677","article-title":"Inhibition of metalloproteinase cleavage enhances the cytotoxicity of Fas ligand","volume":"170","author":"Knox","year":"2003","journal-title":"J Immunol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0215","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/archderm.140.2.242","article-title":"Kinetics and specificity of fas ligand induction in toxic epidermal necrolysis","volume":"140","author":"Chang","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0220","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/cncr.10277","article-title":"Expression of CD95 (Fas) in sun-exposed human skin and cutaneous carcinomas","volume":"94","author":"Filipowicz","year":"2002","journal-title":"Cancer"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0225","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0002-9440(10)64284-8","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand","volume":"162","author":"Abe","year":"2003","journal-title":"Am J Pathol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0230","first-page":"555","article-title":"The use of intravenous high-dose immunoglobulins (IGIV) in a case of Stevens-Johnson syndrome","volume":"14","author":"Amato","year":"1992","journal-title":"Pediatr Med Chir"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0235","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1523-1747.2000.00037.x","article-title":"Death receptors in cutaneous biology and disease","volume":"115","author":"Wehrli","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0240","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archderm.139.1.33","article-title":"Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression","volume":"139","author":"Bachot","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0245","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","article-title":"MockenhauptM. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study","volume":"58","author":"Schneck","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0250","series-title":"Br J Dermatol","article-title":"Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis","author":"Valeyrie-Allanore","year":"2010"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0255","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.clindermatol.2009.06.020","article-title":"Severe cutaneous adverse drug reactions: who should treat, where and how?: Facts and controversies","volume":"28","author":"Wolf","year":"2010","journal-title":"Clin Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0260","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00128071-200607060-00004","article-title":"Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"7","author":"Mittmann","year":"2006","journal-title":"Am J Clin Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0265","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1067\/mai.2002.120563","article-title":"Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity","volume":"109","author":"Posadas","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0270","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1747.2002.01622.x","article-title":"Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis","volume":"118","author":"Nassif","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0275","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev.iy.08.040190.001431","article-title":"Perforin-mediated target cell lysis by cytolytic T lymphocytes","volume":"8","author":"Tschopp","year":"1990","journal-title":"Annu Rev Immunol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0280","first-page":"1","article-title":"Perforin and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity","volume":"198","author":"Lowin","year":"1995","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0285","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/377446a0","article-title":"Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B","volume":"377","author":"Darmon","year":"1995","journal-title":"Nature"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0290","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1001\/archderm.1994.01690050073012","article-title":"Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis","volume":"130","author":"Paquet","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0295","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00000372-199704000-00005","article-title":"Erythema multiforme and toxic epidermal necrolysis: a comparative study","volume":"19","author":"Paquet","year":"1997","journal-title":"Am J Dermatopathol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0300","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.4049\/jimmunol.162.12.7140","article-title":"Crosstalk between keratinocytes and T lymphocytes via Fas\/Fas ligand interaction: modulation by cytokines","volume":"162","author":"Arnold","year":"1999","journal-title":"J Immunol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0305","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.4049\/jimmunol.162.3.1440","article-title":"TNF receptor p55 plays a pivotal role in murine keratinocyte apoptosis induced by ultraviolet B irradiation","volume":"162","author":"Zhuang","year":"1999","journal-title":"J Immunol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0310","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1046\/j.1365-2133.2000.03784.x","article-title":"High-dose proinflammatory cytokines induce apoptosis of hair bulb keratinocytes in vivo","volume":"143","author":"Ruckert","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0315","first-page":"553","article-title":"Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes","volume":"60","author":"Leverkus","year":"2000","journal-title":"Cancer Res"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0320","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/10577","article-title":"Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB","volume":"5","author":"Wang","year":"1999","journal-title":"Nat Med"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0325","doi-asserted-by":"crossref","first-page":"37957","DOI":"10.1074\/jbc.274.53.37957","article-title":"Role of NF-kappaB in the apoptotic-resistant phenotype of keratinocytes","volume":"274","author":"Qin","year":"1999","journal-title":"J Biol Chem"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0330","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(98)02197-7","article-title":"Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis","volume":"352","author":"Wolkenstein","year":"1998","journal-title":"Lancet"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0335","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.4049\/jimmunol.161.4.1758","article-title":"Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways","volume":"161","author":"Gamen","year":"1998","journal-title":"J Immunol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0340","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.282.5386.121","article-title":"An antimicrobial activity of cytolytic T cells mediated by granulysin","volume":"282","author":"Stenger","year":"1998","journal-title":"Science"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0345","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0161-5890(99)00063-2","article-title":"Biosynthesis of granulysin, a novel cytolytic molecule","volume":"36","author":"Hanson","year":"1999","journal-title":"Mol Immunol"},{"key":"10.2332\/allergolint.10-RAI-0261_bb0350","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.4049\/jimmunol.174.9.5243","article-title":"Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator","volume":"174","author":"Deng","year":"2005","journal-title":"J Immunol"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1323893015306432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1323893015306432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T13:27:59Z","timestamp":1685885279000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893015306432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"alternative-id":["S1323893015306432"],"URL":"https:\/\/doi.org\/10.2332\/allergolint.10-rai-0261","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}